脱氮酶
泛素
化学
亚科
生物化学
酶
细胞毒性
癌细胞
癌症
靶蛋白
计算生物学
癌症研究
体外
生物
基因
遗传学
作者
Youngchai Son,Ji Su Yang,Sang Chul Shin,Seo Kyoung Park,Yeojin Kim,Jin‐Young Park,Jinha Yu
标识
DOI:10.1016/j.bioorg.2024.107222
摘要
Ubiquitination is a representative post-translational modification that tags target proteins with ubiquitin to induce protein degradation or modify their functions. Deubiquitinating enzymes (DUBs) play a crucial role in reversing this process by removing ubiquitin from target proteins. Among them, USP2a has emerged as a promising target for cancer therapy due to its oncogenic properties in various cancer types, but its inhibitors have been limited. In this study, our aim was to optimize the structure of ML364, a USP2a inhibitor, and synthesize a series of its derivatives to develop potent USP2a inhibitors. Compound 8v emerged as a potential USP2a inhibitor with lower cytotoxicity compared to ML364. Cellular assays demonstrated that compound 8v effectively reduced the levels of USP2a substrates and attenuated cancer cell growth. We confirmed its direct interaction with the catalytic domain of USP2a and its selective inhibitory activity against USP2a over other USP subfamily proteins (USP7, 8, or 15). In conclusion, compound 8v has been identified as a potent USP2a inhibitor with substantial potential for cancer therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI